Hanns Mohler
Corporate Officer/Principal bei Swiss Federal Institute of Technology
Profil
Dr. Hanns Moehler, MD, is Vice Director at Swiss National Center of Neuroscience Research, a Principal at Swiss Federal Institute of Technology, a Member at European Academy of Sciences, and a Member at Swiss Academy of Medical Sciences.
He is on the Board of Directors at Newron Pharmaceuticals SpA and AGY Therapeutics, Inc.
Dr. Moehler was previously employed as a Director-Pharmacology Institute by University of Zurich and Vice Director-Research by F.
Hoffmann-La Roche Ltd.
He received his undergraduate degree from the University of Bonn.
Aktive Positionen von Hanns Mohler
| Unternehmen | Position | Beginn |
|---|---|---|
| Swiss Federal Institute of Technology | Corporate Officer/Principal | - |
| Swiss National Center of Neuroscience Research | Corporate Officer/Principal | 04.05.2010 |
| European Academy of Sciences | Corporate Officer/Principal | 04.05.2010 |
| Swiss Academy of Medical Sciences | Corporate Officer/Principal | 04.05.2010 |
Ehemalige bekannte Positionen von Hanns Mohler
| Unternehmen | Position | Ende |
|---|---|---|
| University of Zurich | Corporate Officer/Principal | 01.01.2005 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
| NEWRON PHARMACEUTICALS S.P.A. | Director/Board Member | - |
AGY Therapeutics, Inc.
 AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA. | Director/Board Member | - |
Ausbildung von Hanns Mohler
| University of Bonn | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
AGY Therapeutics, Inc.
AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
| European Academy of Sciences | |
| Swiss National Center of Neuroscience Research | |
| Swiss Academy of Medical Sciences |
